Product Datasheet
Smad2(Phospho-Thr220) Antibody
Catalog Number: 11323
Technical:tech@swbio.com
Information:info@swbio.com
Description
- Swiss-Prot No.:
- Swiss-Prot: Q15796
NCBI Protein: NP _001003652.1
- Form of Antibody:
- Supplied at 1.0mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
- Storage:
- Store at -20°C for long term preservation (recommended). Store at 4°C for short term use.
- Immunogen:
- Peptide sequence around phosphorylation site of threonine 220 (P-E-T(p)-P-P) derived from Human Smad2.
- appl_detail:
- Predicted MW: 60kd
Western blotting: 1:500~1:1000
- other_names:
- JV18-1; MADH2; MADR2; Mad-related protein 2; Mothers against DPP homolog 2
- Purification:
- Antibodies were produced by immunizing rabbits with synthetic phosphopeptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific phosphopeptide. Non-phospho specific antibodies were removed by chromatogramphy usi
- Specificity:
- The antibody detects endogenous level of Smad2 only when phosphorylated at threonine 220.
- Background:
- Transcriptional modulator activated by TGF-beta and activin type 1 receptor kinase. SMAD2 is a receptor-regulated SMAD (R-SMAD). May act as a tumor suppressor in colorectal carcinoma.
Sang Gyun Kim et al. (2004) Mol Biol Cell. February; 15(2): 420
© Signalway Biotechnology All Rights Reserved.